GLYCART biotechnology AG

Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology.

GLYCART biotechnology AG, a 100 % affiliate of Roche Pharmaceuticals, is active in the research, development and commercialization of new potent antibody-based products for the treatment of cancer and autoimmune disease. GLYCART offers a stimulating environment where developing new drugs to treat unmet clinical needs is our goal.

Details


Adresse:
GLYCART biotechnology AG

Wagistrasse 18
8952
Deutschland
Arbeitsgebiet:
Forschung & Lehre
Expansion:
national
Webseite:
Mitarbeiteranzahl:
11-50